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Aim: To estimate potential savings for Australia’s health care system through the implemen-
tation of an innovative Beacon model of care for patients with complex diabetes.
Methods: A prospective controlled trial was conducted comparing a multidisciplinary,
community-based, integrated primary-secondary care diabetes service with usual care at
a  hospital diabetes outpatient clinic. We  extracted patient hospitalisation data from the
Queensland Hospital Admitted Patient Data Collection and used Australian Refined Diagno-
sis  Related Groups to assign costs to potentially preventable hospitalisations for diabetes.
Results: 327 patients with complex diabetes referred by their general practitioner for special-
ist  outpatient care were included in the analysis. The integrated model of care had potential
for  national cost savings of $132.5 million per year.
Conclusions: The differences in hospitalisations attributable to better integrated pri-ost savings mary/secondary care can yield large cost savings. Models such as the Beacon are highly
relevant to current national health care reform initiatives to improve the continuity and
efficiency of care for those with complex chronic disease in primary care.
ry Ca©  2017 Prima
.  Introduction
otentially preventable hospitalisations are those consideredPlease cite this article in press as: S.A. Hollingworth, et al., Impact of a gene
preventable diabetes-related hospitalisations, Prim. Care Diab. (2017), http
voidable if preventive care and early disease management
n the community had been provided [1,2]. Diabetes-
elated hospitalisations contribute substantially to potentially
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preventable hospitalisations in Australia and include compli-
cations of diabetes and changes in glycaemia. In 2013–2014,
6.8% of preventable hospitalisations were related to diabetes
complications [3].ral practitioner-led integrated model of care on the cost of potentially
://dx.doi.org/10.1016/j.pcd.2017.03.009
.donald@sph.uq.edu.au (M. Donald), jenny.zhang@uq.edu.au (J.
2@health.qld.gov.au (A. Russell), c.jackson@uq.edu.au (C. Jackson).
Australia is a federation of six states and two  territories and
there are overlapping but separate responsibilities for health
by the national government (often called the Commonwealth)
and state and territory governments.
Ltd. All rights reserved.
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Medicare is the national universal health insurance
scheme which covers most of the out-of-hospital medical
services costs, such as general practitioner (GP) visits and
specialist consultations [4]. All permanent Australian resi-
dents are entitled to free public hospital care when admitted
to hospital as public patients. Public hospital costs are the
responsibility of state and territory governments, while most
primary care services are funded by the national government.
People with complex conditions often see a specialist as an
outpatient in a public hospital (secondary care) and these spe-
cialists should work collaboratively with the person’s GP in
primary care [4].
We  have advocated for an integrated GP-led model
of care, the Beacon model, to manage chronic diseases
including diabetes [5,6]. We compared this multidisciplinary,
community-based, integrated primary-secondary model of
care with usual hospital-based outpatient services for patients
with complex type 2 diabetes mellitus (T2DM) referred by their
usual GP for specialist review, and showed the effectiveness
of the model on clinical outcomes as well as consumer sat-
isfaction [7,8]. Moreover, patients receiving the model of care
had fewer potentially preventable hospitalisations when the
principal diagnosis for admission was a diabetes-related com-
plication (PPH-D). Specifically, the average number of PPH-D in
the usual care group was 0.35 per patient and in the interven-
tion group was 0.19 per patient (crude incidence rate ratio 0.53,
95%CI 0.29, 0.96; p = 0.04) [9]. In this report, we  aimed to esti-
mate the cost savings associated with these reduced PPH-D in
the integrated model of care.
2.  Methods
We  recruited 330 patients to a prospective controlled trial
(August 2007–April 2008). Three patients were excluded from
this analysis: two did not complete any assessments and one
was in a psychiatric hospital for an extended period of time.
The methods for the study have been described elsewhere [6,8]
but, briefly, patients with complex T2DM referred by their GP
for specialist outpatient care were invited to have their dia-
betes managed via our community-based integrated service
where GPs with a special interest and advanced training in
diabetes worked alongside an endocrinologist and diabetes
educator. Patients were discharged back to their referring GP
once clinical targets were achieved or after 12 months if it
was felt no further improvement could be achieved. The study
was granted ethics approval by the Metro South Brisbane
Health Service District and linkage with hospitalisations data
was approved under the delegation of the Director-General,
Queensland Department of Health.
Hospitalisations data were originally obtained using ICD-
10-AM codes and data linkage techniques to combine
routinely collected hospitalisation data from the Queensland
Hospital Admitted Patient Data Collection (QHAPDC) with the
study’s dataset [9]. For the analysis reported here we subse-
quently obtained the Australian Refined – Diagnosis-RelatedPlease cite this article in press as: S.A. Hollingworth, et al., Impact of a gene
preventable diabetes-related hospitalisations, Prim. Care Diab. (2017), http
Group (DRG) for each hospitalisation. This is an admitted
patient classification system that provides a clinically mean-
ingful way of relating the number and type of patients treated
in a hospital to the resources required by the hospital. Wex x x ( 2 0 1 7 ) xxx–xxx
analysed costs for both PPH-D and non diabetes-related hos-
pitalisations (nonDH) given that there were significantly more
nonDH in the intervention than usual care group (crude
incidence rate ratio 1.44 95%CI 0.94, 2.21; p = 0.09; adjusted
incidence rate ratio 1.92 95%CI 1.20, 2.80 p = 0.01) [9]. The costs
for the PPH-D and nonDH, based on DRGs, were extracted
from online reports published by the Department of Health
for each of the three corresponding financial years (2007–2008;
2008–2009; and 2009–2010) [10].
Our purpose is to estimate the savings associated with
the reduction in PPH-D reported in the original analysis [9].
We  determined the total cost of PPH-D (and nonDH) hos-
pitalisations for each group by summing the DRG costs of
each hospitalisation for both groups. The average cost per
hospitalisation was calculated by dividing the total cost of hos-
pitalisations by the total number of hospitalisations for each
group separately. Assuming a national roll out of this model
would achieve similar benefits, we estimated the national
potential savings for PPH-D using 2013–2014 hospitalisation
numbers as reported by the Australian Institute of Health
and Welfare [11] and inflation adjusted average cost per
hospitalisation in 2014 dollars. All calculations are in Aus-
tralian dollars. The exchange rate averaged over the time
period from July 2007 to June 2010 was AUD$1 = D 0.5970 and
AUD$1 = GBP£0.4919 [12].
3.  Results
For the 327 patients, there were 85 PPH-D corresponding to
20 specific AR-DRGs. As noted previously, the average PPH-D
hospitalisation rate was 0.35 for usual care and 0.19 for the
intervention group over a 24 month period. The average cost
per patient was calculated as the average cost per hospital
admission multiplied by the average number of admissions
per patient. It was less in the intervention group (AUD$1425)
than usual care group (AUD$2527). There were 26,900 hos-
pitalisations with T2DM recorded as the principal diagnosis
in Australia for the fiscal year 2013–2014. Using the inflation
adjusted estimate of $9608 per PPH-D hospitalisation in usual
care, the cost would have been $258.4 million (2014 $AUD)
in 2014 (Table 1). Assuming the 47% reduction in hospitalisa-
tions in the intervention group, the savings from potentially
avoidable hospitalisations would be AUD$132.5 million in 2014
(D 79.1 million, GBP£65.2 million).
There were 240 nonDH and the average hospitalisation rate
was 0.59 for usual care (n = 85 events) and 0.85 for the interven-
tion group (n = 155 events) over a 24 month period. The average
cost per hospital admission was lower in the intervention than
in the usual care group (usual care AUD$11,006; intervention
AUD$7585; difference AUD$3422). There was little difference
in the average cost per patient, AUD$6447 for the intervention
group and AUD$6494 for usual care group, (a saving of $47 with
intervention).
4.  Discussionral practitioner-led integrated model of care on the cost of potentially
://dx.doi.org/10.1016/j.pcd.2017.03.009
Leveraging the quality and efficiency benefits of better inte-
grated care is now a national priority for governments,
consumers, and health care providers [13]. Integrated primary-
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Table 1 – Potentially preventable diabetes-related hospitalisations and costs by treatment group.
Usual care (n = 145) Intervention (n = 182) Difference
Total number of PPH-D 51 34
Average number PPH-D per patient 0.35 0.19 0.16a (47% reduction)
Total cost $368,224  $255,189 $ 113,035
Average cost per PPH-D (range) $7220 ($1817–$35,624) $7505 ($1817–$34,257) −$285
Average cost per patientb $2527 $1425 $1,102
Extrapolation to national level
Hospitalisation for T2DM as principal diagnosis 2013–2014 26,900c 12,612d
Average cost per PPH-D 2014 $9608 $9988
Estimated cost 2014 $258,469,119 $125,978,694 $132,490,425 (saving)
a Statistically significant at p < 0.05 as reported in Zhang et al. [9].
b Average cost per patient = average cost per PPH-D × average number PPH-D per patient.
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d 47% reduction from 26,900.
econdary care can reduce both the number and associated
ost of PPH-D whilst preserving care quality [9,14]. If these
avings from PPH-D are extrapolated to all similar hospital-
sations in Australia then the savings are in the realm of
UD$132.5 million annually. The differences in hospitalisa-
ions attributable to specific interventions in primary care can
herefore yield large cost savings and improve public health
n the wider context. Building primary care capacity might be
ore important than care coordination for preventing hospi-
alisations in people with diabetes [15].
A limitation of our study is the non-randomised study
esign and the small numbers of patients and subsequent
ospitalisations. The research team are currently conduct-
ng a randomised controlled trial with the aim of building
n these findings [8]. Our original analysis reported a higher
ate of admissions for non-diabetes related conditions among
he Beacon model patients [9], which is consistent with a
tudy of non-elective re-admissions to an acute hospital in
he United Kingdom [16]. We argued that, in the absence
f a biologically plausible explanation, more  holistic mod-
ls of care are likely to detect other conditions in this more
ocially disadvantaged group [17]. Furthermore, the identifica-
ion of non-preventable conditions improves patient care and
arly identification might prevent more  serious presentations.
ndeed, in this study we  costed the nonDH and found little
ifference in the average cost per patient for the intervention
ersus usual care. So, although there were more  admissions in
he intervention group, the costs per patient were similar and
herefore no need to adjust our main PPH-D costing analysis.
Despite the estimated savings, we acknowledge the sig-
ificant financial, structural and operational challenges if the
eacon model were to be implemented across Australia. It is
ow broadly accepted that the context in which health care
nnovations take place is hugely important to their success
18,19]. A ‘one size fits all’ approach to models of health care is
nlikely to be appropriate in such diverse settings [20]. Instead,
 small suite of evidence-based models of care that can be
dopted by Hospital and Health Services and Primary Health
etworks would provide local health care networks the flexi-
ility to consider their local contexts. The Beacon model wasPlease cite this article in press as: S.A. Hollingworth, et al., Impact of a gene
preventable diabetes-related hospitalisations, Prim. Care Diab. (2017), http
esigned as a small-scale, locally led and co-created innova-
ion and this remains one of its strengths. It is now Queenslandnberra: AIHW, 2014 [11].
Health’s preferred model for outpatient substitution, with
communities adapting it to be locally fit-for-purpose [21].
We have demonstrated that, apart from its positive impact
on clinical outcomes, the Beacon model also has potential
to make significant savings for Australia’s health care sys-
tem through avoided hospitalisations. Such a model is highly
relevant to current national health care reform initiatives
in primary care, Medicare, and private health insurance, to
improve the continuity and efficiency of care for complex
chronic disease in primary care.
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